Has Suneil Jolly, MD received payments from drug or device companies?

Yes. Drug and device makers reported $465,323 in general payments to Suneil Jolly, MD across 534 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Suneil Jolly, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Suneil Jolly, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Suneil Jolly, MD

Interventional Pain Medicine · Kenner, LANPI 1073807509

Payments from drug & device makers

$465,323in general payments, 2019–2025

Across 534 payments — averaging $871.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$404K
Daiichi Sankyo Inc.$30K
Abbott$28K
Nevro Corp.$398
Medtronic$285
Stryker$219
plus $2K from 37 others

What the payments were for

Consulting fees$23,74322%
Speaking & faculty fees$66,27462%
Travel & lodging$8,1578%
Food & beverage$8,9728%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	213	$404,046
Daiichi Sankyo Inc.	23	$30,241
Abbott	164	$27,877
Nevro Corp.	7	$398
Medtronic(2 entities)	10	$285
Stryker	4	$219
Johnson & Johnson	11	$211
Biotronik NRO, Inc.	7	$195
Painteq LLC	2	$172
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$161
Si-bone, Inc.	4	$157
Sentynl Therapeutics, Inc.	13	$127
Amgen(2 entities)	6	$94
Scilex Pharmaceuticals Inc.	6	$87
IBSA Pharma Inc.	4	$67
Saluda Medical Americas, Inc.	2	$65
Globus Medical	1	$64
Biodelivery Sciences International, Inc.	4	$58
Zyla Life Sciences, Inc.	4	$57
Brixton Biosciences, Inc.	1	$55
Redhill Biopharma Inc.	3	$53
Baudax Bio Inc.	3	$49
Pfizer	3	$47
Spinal Simplicity, LLC	2	$44
Tersera Therapeutics LLC	2	$43
Collegium Pharmaceutical, Inc.	3	$41
Valinor Pharma, LLC	2	$39
Orthogenrx Inc.	2	$38
Trevena, Inc.	2	$35
Almatica Pharma LLC	2	$34
Virtus Pharmaceuticals LLC	2	$33
Stimwave Technologies Incorporated	2	$29
Bioventus LLC	1	$27
Kaleo, Inc.	2	$25
Shionogi Inc	1	$21
Pacira Therapeutics, Inc.	1	$20
Kowa Pharmaceuticals America, Inc.	1	$19
Novartis	1	$18
Advanced Oxygen Therapy Inc.	1	$17
Arbor Pharmaceuticals, Inc.	1	$15
Ferring Pharmaceuticals Inc.	1	$15
Nalu Medical, Inc.	1	$13
MDD US Operations, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$465,323 in reported general payments places this provider in the 95th percentile of 57 interventional pain medicine providers in Louisiana.

See all interventional pain medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$9,816

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	150	$2,928
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	144	$2,329
Lidocaine	20	$2,175
Diclofenac Sodium	42	$1,400
Tizanidine Hcl	86	$677
Gabapentin	56	$661
Pregabalin	28	$265
Methocarbamol	22	$165
Naproxen	16	$157
Duloxetine Hcl	14	$137
Meloxicam	58	$132
Cephalexin	12	$110
Tramadol Hcl	32	$82
Cyclobenzaprine Hcl	12	$64

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Kenner

Tarun JollyKenner$263
Maged GuirguisNew Orleans$1.7M
Adam CarinciBaton Rouge$92K
John CefaluShreveport$71K
Steve LeeSlidell$61K
William WhyteShreveport$39K
Paul HubbellMetairie$33K
Ken EhrhardtHammond$22K
Thomas BerryLacombe$21K
Randall BrewerShreveport$20K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →